It has been suggested that COX-inhibitors may sensitize cancer cells to chemotherapeutic drugs via inhibiting P-gp, MRP1 and BCRP, and enhance the effect of anticancer drugs [27]. This evidence concerns the gene ABCG2 and cancer.